Glenmark Life Sciences informs about board meeting

17 Oct 2024 Evaluate

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Glenmark Life Sciences has informed that a meeting of the Board of Directors will be held on Thursday, October 24, 2024, to consider and approve the Unaudited Financial Results, of the Company for the second quarter and half year ended 30th September, 2024. Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window from September 30, 2024 to October 26, 2024 for the purpose of approval of Unaudited Financial Results for second quarter and half year ended September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

1012.55 -5.30 (-0.52%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.